Clinical trial
Efficacy of Antiplatelet Therapy for the Treatment of Chronic Recalcitrant Urticaria
NCT06268470 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Antiplatelet Therapy for the Treatment of Chronic Recalcitrant Urticaria
- Lead sponsor
- Chulalongkorn University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 1, 2018
- Completion date
- May 1, 2024
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.